Judge signs off on Teva's $35M settlement over delayed inhaler generics
A Massachusetts federal judge on Wednesday approved a $35 million settlement between Teva Pharmaceuticals and a handful of healthcare funds over allegations the company delayed generic versions of its asthma inhalers, causing higher prices. The ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.


